Improving Pharmaceutical & Life Sciences Performance with Big Data

The ability to access, analyze, and manage vast volumes of data while rapidly evolving the Information Architecture has long been critical to pharmaceutical and life sciences companies as they improve business efficiency and performance. While accelerated drug development that drives improved drug pipelines and more complete clinical trials and the ability to predict failure early remain keys to success, better analysis of patient adherence and improving time to market for new drugs helps to maximize overall profitability.

Spotlight

Anka Behavioral Health, Inc.

For over 40 years, Anka Behavioral Health, Inc. (Anka) has partnered with public and private sector behavioral health organizations to provide recovery-based services to the mental health and social services community. Anka currently operates 80 behavioral health programs, providing services to nearly 16,000 men, women, transitional aged youth, children, and their families annually. Anka's programming places a special emphasis on providing comprehensive services which speak to multiple aspects of an individual's recovery.

OTHER WHITEPAPERS
news image

Personalizing Radiotherapy in Oncology: The Evolution of Treatment

whitePaper | January 9, 2020

Radiation therapy is one of the most common treatments used to fight cancer in the U.S., with more than half of cancer patients receiving it either alone or in combination with other medical interventions.1 With the traditional approach to radiation therapy, the dose and schedule is tailored to the tumor type, location, and stage of growth, but only infrequently updated in light of changes after treatment starts. Experts in adaptive therapy are looking to deliver a more personalized treatment strategy guided by the individual patient’s needs.

Read More
news image

Future of medical science

whitePaper | May 14, 2022

Medical science is currently being transformed by scientific discoveries that will dramatically advance the way we diagnose and treat different diseases.

Read More
news image

THE FUTURE OF HEALTHCARE

whitePaper | April 7, 2022

The global healthcare industry is facing a seemingly insurmountable number of challenges – from aging populations and staff shortages to rising costs

Read More
news image

The 2022 Healthcare Cyber Trend Research Report

whitePaper | June 15, 2022

Infoblox is pleased to publish our 2022 Healthcare Cyber Trend Research Report. This report includes analysis of the major healthcare data breaches directly attributed to cyber attacks within the United States during calendar year 2021.

Read More
news image

DIGITAL HEALTH

whitePaper | April 28, 2022

The authors would like to express their gratitude to those who contributed to this research either by participating in the surveys carried out during the EIT Health Morning Health Talks or the in-depth interviews.

Read More
news image

2022 Global Predictions Whitepaper

whitePaper | January 14, 2022

In the past year, more than nine billion doses of coronavirus vaccines have been administered, in at least 197 countries worldwide according to the BBC and Oxford University.

Read More

Spotlight

Anka Behavioral Health, Inc.

For over 40 years, Anka Behavioral Health, Inc. (Anka) has partnered with public and private sector behavioral health organizations to provide recovery-based services to the mental health and social services community. Anka currently operates 80 behavioral health programs, providing services to nearly 16,000 men, women, transitional aged youth, children, and their families annually. Anka's programming places a special emphasis on providing comprehensive services which speak to multiple aspects of an individual's recovery.

Events